China Taiping Insurance Holdings Company Limited 2025 Annual Results Presentation March 2026 Forward-Looking Statements and Declarations This presentation and the ensuing discussions may contain certain forward-looking statements regarding the financial condition, results of operations and businesses of China Taiping Insurance Holdings Company Limited. Such forward-looking statements represent China Taiping Insurance Holdings Company Limited's expectations or beliefs about future events, including known or ...

ile 77 ock Code : 1093) 2025 Results Presentation IND approvals : North America (18) China (58) Mar. 2026 INNOVAT 2025 Updates Regulatory Updates New drugs approved (including new indications): Breakthrough Therapy Designations: Major Clinical Trial Progress New pivotal clinical trials: Shareholder Return Since the beginning of the year 2025, a total of HK$ 4 been repurchased (including HK$153 million for equity incentive plan). The full-year dividend per share is HK Z cents (including interim dividend of H ...

A n n u a l R e s u l t s P r e s e n t a t i o n 2025 二零二五年全年業績發佈會 Results Highlights – Steadily advancing mid-to-long term strategy Revenue topped RMB80 billion Excellent cash 1 generating capability 4 Maintained high operating efficiency 2 3 RMB ANTA FILA Profit attributable to Equity Shareholders 1 RMB 13.9% 13.59 billion All other brands 17.00 billion ANTA FILA Revenue Operating Profit Margin 28.47 billion 6.9% 26.1% 0.8 ppts 80.22 billion 13.3% 23.8% 0.4 ppts 34.75 billion 3.7% 20.7% 0.3 ppts All othe ...

H&H Annual Results 2025 MARCH 2026 2025 ANNUAL RESULTS 2 2025 ANNUAL RESULTS Disclaimer These materials have been prepared solely for the use at the presentation by Health and Happiness (H&H) International Holdings Limited ("the Company") and have not been independently verified. No representation or warranty, expressed or implied, is made and no reliance should be placed on the accuracy, fairness, correctness or completeness of the information presented or contained in these materials. The Company or any o ...

Disclaimer The information contained in this presentation is intended solely for your personal reference. In addition, such information contains projections and forward-looking statements that reflect the Company's current views with respect to future events and financial performance. These views are based on assumptions subject to various risks. No assurance can be given that future events will occur, that projections will be achieved, or that the Company's assumptions are correct. Actual results may diffe ...

Cautionary Statements Regarding Forward-looking Statements This presentation is provided by Ping An Healthcare and Technology Company Limited (hereinafter referred to as the "Company"). To the extent any statements made in this report contain information that is not historical, these statements are essentially forward-looking. These forward-looking statements include but are not limited to projections, targets, estimates and business plans that the Company expects or anticipates will or may occur in the fut ...

ANNOUNCEMENT 2025 ANNUAL RESULTS 24 March 2026 Copyright 2026, Nexteer Automotive Corporation. All rights reserved. 1 CONFIDENTIAL Safe Harbor Statement These materials have been prepared by Nexteer Automotive Group Limited ("Nexteer" or the "Company") and are being furnished to you solely for informational purposes. The information contained in these materials has not been independently verified. NO REPRESENTATION OR WARRANTY EXPRESS OR IMPLIED IS MADE AS TO, AND NO RELIANCE SHOULD BE PLACED ON, THE FAIRNE ...

Disclaimer Sisram Medical 2025 Annual Earnings Presentation Stock Code: 1696.HK 2 2025 Snapshot Revenue US$ 365.3 M +4.7% YoY Revenue from APAC Revenue from Injectables US$ 147.4M +185.6 % YoY +26.9% YoY US$ 28.0 M International Markets (Excl. NA) US$ 254.3 M +20.1% YoY Gross Profit Margin 58.9 % - 3.2 p.p. YoY Adjusted Net Profit Margin 8.5 % +0.3 p.p. YoY 1 3 Global Expansion at A Glance Reinforcing our leadership across core and emerging markets, as we continue to scale globally with focus and agility Di ...

Tongcheng Travel Holdings Limited Stock Code: 0780 Investor Presentation March 2026 Disclaimer The materials used in this investors presentation are being furnished to you for your information only, which shall be kept in strict confidence. No representation or warranty, express or implied, is made by Tongcheng Travel Holdings Limited (the "Company") or its connected person, or any of their respective directors, officers, employees, advisers or representatives as to, and no reliance should be placed on, the ...

Xiaomi Corporation 2025 Fourth Quarter and Annual Results Disclaimer By attending the meeting where this presentation is made, or by reading the presentation materials, you agree to be bound by the following limitations: The information in this presentation has been prepared by representatives of Xiaomi Corporation (the "Company", and together with its subsidiaries, the "Group") for use in presentations by the Group and does not constitute a recommendation regarding the securities of the Group. No part of t ...